Skip to content
The Nexus
DossierENTITY

Universities of Cambridge and Southampton

Coverage of Universities of Cambridge and Southampton in the Nexus archive.

Earliest in view: Jun 13 · 20:59 UTCMost recent: Jun 13 · 20:59 UTC
Co-mentioned in this coverage
Saul Faustperson1AI-designed universal vaccinetopic1Sarbeco coronavirusestopic1SARS-CoV-2topic1micro-fluid jet deliverytopic1AI in medicinetopic1
Recent coverage
  • HEALTHJun 13 · 20:59 UTCFOX NEWS
    AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics

    An AI-designed 'universal vaccine' targeting multiple coronaviruses has passed its first human clinical trial, showing safety and triggering an immune response in 39 volunteers. Developed by researchers from the Universities of Cambridge and Southampton, the vaccine uses a computer-simulated 'super-antigen' to combat evolving viruses, including those not yet discovered. The needle-free micro-fluid jet delivery method aims to simplify mass administration.

Universities of Cambridge and Southampton · Dossier · The Nexus